Zivo Bioscience Correlations
ZIVOWDelisted Stock | USD 0.55 0.07 14.58% |
The correlation of Zivo Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Zivo Bioscience Correlation With Market
Good diversification
The correlation between Zivo Bioscience Warrants and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Zivo Bioscience Warrants and DJI in the same portfolio, assuming nothing else is changed.
Zivo |
Moving together with Zivo Stock
0.68 | CEROW | CERo Therapeutics Symbol Change | PairCorr |
0.73 | FNCH | Finch Therapeutics | PairCorr |
0.62 | FBIOP | Fortress Biotech Pref | PairCorr |
Moving against Zivo Stock
0.71 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
0.39 | ZBIO | Zenas BioPharma, Common | PairCorr |
0.68 | XOMAO | XOMA | PairCorr |
0.62 | OKUR | OnKure Therapeutics, Symbol Change | PairCorr |
0.59 | XOMAP | XOMA Corp | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Zivo Stock performing well and Zivo Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Zivo Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
META | 1.06 | 0.06 | 0.02 | 0.20 | 1.40 | 2.62 | 8.02 | |||
MSFT | 0.92 | (0.05) | (0.05) | 0.05 | 1.49 | 2.09 | 8.19 | |||
UBER | 1.62 | (0.12) | (0.05) | 0.00 | 2.30 | 2.69 | 20.10 | |||
F | 1.43 | 0.02 | (0.04) | 0.48 | 2.24 | 2.53 | 11.21 | |||
T | 0.92 | 0.28 | 0.15 | (7.88) | 0.85 | 2.56 | 6.47 | |||
A | 1.17 | (0.09) | 0.00 | (0.05) | 0.00 | 2.71 | 9.02 | |||
CRM | 1.34 | 0.21 | 0.16 | 0.30 | 1.16 | 3.18 | 9.09 | |||
JPM | 1.12 | (0.01) | 0.06 | 0.11 | 1.40 | 2.05 | 15.87 | |||
MRK | 0.91 | (0.21) | 0.00 | (0.74) | 0.00 | 2.00 | 4.89 | |||
XOM | 1.01 | (0.05) | (0.08) | 0.02 | 1.33 | 2.10 | 5.74 |
Zivo Bioscience Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zivo Bioscience stock to make a market-neutral strategy. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Zivo Bioscience Corporate Management
Casey Fowler | VP Devel | Profile | |
David Lafond | VP Technology | Profile | |
Harlan III | Vice Supply | Profile | |
Keith Marchiando | Treasurer CFO | Profile | |
Andrew Dahl | CEO Pres | Profile | |
Scott Freeman | Chief Officer | Profile |
Still Interested in Zivo Bioscience Warrants?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.